SCHEMBL64211

SCHEMBL64211

CC(N1CCN(CCO)CC1)S(=O)(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 2/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
OPRD1 P41143 1/20 0.35
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RORC P51449 1/20 0.33
TERT O14746 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
HSD11B1 P28845 1/20 0.33
MEN1 O00255 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22345800 0.98 CHRM2 (0.46) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL3178617 0.98 CHRM2 (0.46) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL348916 0.92 CHRM2 (0.42) CHRM2CHRM1ALDH1A1KDM4EPOLB
Hydrochloric Acid SCHEMBL310122 0.91 CHRM2 (0.41) CHRM2CHRM1ALDH1A1KDM4EPOLB
Tromethamine SCHEMBL28290526 0.89 CHRM2 (0.40) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL1662667 0.84 CHRM2 (0.34) CHRM2CHRM1ALDH1A1KMT2AHTT
SCHEMBL1061900 0.84 CHRM2 (0.34) CHRM2CHRM1ALDH1A1KMT2AHTT
SCHEMBL10781958 0.82 CHRM2 (0.48) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL62393 0.82 KDM4E (0.32) KDM4ELMNA
SCHEMBL7620767 0.81 KDM4E (0.38) ALDH1A1KDM4EPOLBKMT2AHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9706 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12593837-B2 Retinal pigment epithelium cell compositions CELL CURE NEUROSCIENCES LTD. (IL) 2026-04-07 US claimed
EP-4700127-A1 METHOD FOR PREPARING GENE-EDITED CHICKEN China Agricultural University (CN) 2026-02-25 EP claimed
US-20250312297-A1 REDUCTION OF HEALTHCARE RESOURCE UTILIZATION BY PATIENTS TREATED WITH INTRANASALLY-ADMINISTERED METOCLOPRAMIDE EVOKE PHARMA, INC. 2025-10-09 US claimed
US-20250302777-A1 METHODS FOR TREATING GASTROPARESIS EVOKE PHARMA, INC. 2025-10-02 US claimed
US-20250296078-A1 TREATING WASTE STREAMS WITH ADVANCED SEPARATION TECHNOLOGIES NEW MATTOCK RESOURCES, INC. (US) 2025-09-25 US claimed
EP-4618956-A1 LYOPHILIZATION BUFFERS FOR PEPTIDE-DECORATED LIPOSOMES Haima Therapeutics, LLC (US) 2025-09-24 EP claimed
US-20250275531-A1 STABILIZATION MEDIUM FOR EXTENDING TEMPORAL VIABILITY OF HUMAN SEMEN RAMACHANDRAN ASHWIN (AU) 2025-09-04 US claimed
US-20250262248-A1 METHODS AND COMPOSITIONS FOR TREATING VISION LOSS CELL CURE NEUROSCIENCES, LTD. (IL) 2025-08-21 US claimed
US-12369569-B1 Method for generating genome-edited chickens CHINA AGRICULTURAL UNIVERSITY (CN) 2025-07-29 US claimed
US-20250228803-A1 NASAL FORMULATIONS OF METOCLOPRAMIDE EVOKE PHARMA, INC. 2025-07-17 US claimed
WO-1998015614-A1 ANIMAL CELL CULTURE MEDIA COMPRISING PLANT-DERIVED NUTRIENTS LIFE TECHNOLOGIES, INC. (US) 1998-04-16 WO claimed
US-5728375-A ADMINISTERING A COMPOUND COMPRISING AN ANIONIC GROUP AND A CARRIER MOLECULE; INHIBITS DEPOSITION BY PREVENTING INTERACTION BETWEEN AN AMYLOIDOGENIC PROTEIN AND A BASEMENT MEMBRANE CONSTITUENT QUEEN'S UNIVERSITY AT KINGSTON (CA) 1998-03-17 US claimed
WO-1998008934-A1 SERUM-FREE MAMMALIAN CELL CULTURE MEDIUM, AND USES THEREOF LIFE TECHNOLOGIES, INC. (US) 1998-03-05 WO claimed
US-5633162-A Method for culturing Chinese hamster ovary cells GLAXO WELLCOME INC. (US) 1997-05-27 US claimed
US-5453378-A Diagnostic test system verification method using serum free glucose control containing quaternary ammnonium polymer MILES INC. (US) 1995-09-26 US claimed
WO-1995004276-A1 PHYSIOLOGICAL AND ISOTONIC BUFFER COMPATIBLE WITH ATP-LUCIFERASE BIOLUMINESCENCE REACTION FIREZYME DIAGNOSTIC TECHNOLOGIES LTD. (CA) 1995-02-09 WO claimed
EP-0488583-A2 Improved kit and method for administration of bacillus calmette-guerin The Jewish Hospital of St. Louis (US) 1992-06-03 EP claimed
EP-0216179-B1 METHOD FOR DETERMINING PROTEASE INHIBITORS BEHRINGWERKE Aktiengesellschaft (DE) 1991-08-21 EP claimed
EP-0099812-B1 REAGENT FOR THE DIAGNOSIS OF PARASITOSIS AND ALLERGIES, METHOD FOR THE PREPARATION OF THIS REAGENT AND METHOD OF DIAGNOSING PARASITOSIS AND ALLERGIES USING THIS REAGENT INSTITUT PASTEUR (FR) 1987-04-29 EP claimed
US-4637977-A REACTING WITH A RADIOLABELLED 2'-DEOXY-5-HALOURIDEN, PHOSPHORYLATING; DIAGNOSIS AND MONITORING OF CANCERS, TUMORS, VIRUSES GRONOWITZ JAN S (SE) 1987-01-20 US claimed